Author Title [ Type(Desc)] Year
Filters: Author is Zhang, Qing  [Clear All Filters]
Journal Article
Zhang Q, Ma L, Zheng S, Wang Y, Feng M, Shuai Y, Duan B, Fan X, Yang M, Mao C. Air-plasma treatment promotes bone-like nano-hydroxylapatite formation on protein films for enhanced in vivo osteogenesis. Biomater Sci. 2019.
He K, Ma X, Xu T, Li Y, Hodge A, Zhang Q, Torline J, Huang Y, Zhao J, Ling K, et al. Axoneme polyglutamylation regulated by Joubert syndrome protein ARL13B controls ciliary targeting of signaling molecules. Nat Commun. 2018;9(1):3310.
Zhang Q, Yi D-Y, Xue B-Z, Wen W-W, Lu Y-P, Abdelmaksou A, Sun M-X, Yuan D-T, Zhao H-Y, Xiong N-X, et al. CD90 determined two subpopulations of glioma-associated mesenchymal stem cells with different roles in tumour progression. Cell Death Dis. 2018;9(11):1101.
Yu J-M, Wang Z-H, Liu N, Zhang Q, Dong Y-J, Duan Z-J. Complete genome of a novel recombinant human astrovirus and its quasispecies in patients following hematopoietic stem cell transplantation. Virus Res. 2020:198138.
Hamadeh IS, Zhang Q, Steuerwald N, Hamilton A, Druhan LJ, McSwain M, Diez Y, Rusin S, Han Y, Symanowski J, et al. Effect of CYP3A4, CYP3A5 and ABCB1 Polymorphisms on Intravenous Tacrolimus Exposure and Adverse Events in Adult Allogeneic Stem Cell Transplant Patients. Biol Blood Marrow Transplant. 2018.
Zhang Q, Dong H, Li Y, Zhu Y, Zeng L, Gao H, Yuan B, Chen X, Mao C. Microgrooved Polymer Substrates Promote Collective Cell Migration To Accelerate Fracture Healing in an in Vitro Model. ACS Appl Mater Interfaces. 2015.
Jia J, Feng X, Xu W, Yang S, Zhang Q, Liu X, Feng Y, Dai Z. MiR-17-5p modulates osteoblastic differentiation and cell proliferation by targeting SMAD7 in non-traumatic osteonecrosis. Exp Mol Med. 2014;46:e107.
Bhutani M, Foureau D, Zhang Q, Robinson M, Wynn AS, Steuerwald NM, Druhan LJ, Guo F, Rigby K, Turner M, et al. Peripheral Immunotype Correlates with Minimal Residual Disease Status and is Modulated by Immunomodulatory Drugs (IMiDs) in Multiple Myeloma. Biol Blood Marrow Transplant. 2018.